Tyra Biosciences (TYRA) Shares Outstanding (Weighted Average) (2020 - 2026)
Quarterly Shares Outstanding (Weighted Average) rose 4.06% to $61.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $61.7 million through Mar 2026, up 4.06% year-over-year, with the annual reading at $6.4 million for FY2025, 88.85% down from the prior year.
Tyra Biosciences filings provide 7 years of Shares Outstanding (Weighted Average) readings, the most recent being $61.7 million for Q1 2026.
- Shares Outstanding (Weighted Average) hit $61.7 million in Q1 2026 for Tyra Biosciences, up from $6.4 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $61.7 million in Q1 2026 and bottomed at $6.4 million in Q4 2025.
- Average Shares Outstanding (Weighted Average) over 5 years is $47.7 million, with a median of $42.9 million recorded in 2023.
- The largest annual shift saw Shares Outstanding (Weighted Average) surged 2019.35% in 2022 before it tumbled 88.85% in 2025.
- Tyra Biosciences' Shares Outstanding (Weighted Average) stood at $42.6 million in 2022, then rose by 0.6% to $42.9 million in 2023, then soared by 33.43% to $57.2 million in 2024, then tumbled by 88.85% to $6.4 million in 2025, then skyrocketed by 867.51% to $61.7 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Shares Outstanding (Weighted Average) are $61.7 million (Q1 2026), $6.4 million (Q4 2025), and $59.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 104.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.04 Bn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 61.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.75 Mn |
| Dec 31, 2025 | 6.38 Mn |
| Sep 30, 2025 | 59.52 Mn |
| Jun 30, 2025 | 59.55 Mn |
| Mar 31, 2025 | 59.34 Mn |
| Dec 31, 2024 | 57.22 Mn |
| Sep 30, 2024 | 56.64 Mn |
| Jun 30, 2024 | 58.67 Mn |
| Mar 31, 2024 | 52.23 Mn |
| Dec 31, 2023 | 42.88 Mn |
| Sep 30, 2023 | 42.82 Mn |
| Jun 30, 2023 | 42.72 Mn |
| Mar 31, 2023 | 42.39 Mn |
| Dec 31, 2022 | 42.63 Mn |
| Sep 30, 2022 | 41.78 Mn |
| Jun 30, 2022 | 41.67 Mn |
| Mar 31, 2022 | 42.59 Mn |
| Dec 31, 2021 | 13.78 Mn |
| Sep 30, 2021 | 9.16 Mn |
| Jun 30, 2021 | 2.27 Mn |
| Mar 31, 2021 | 2.01 Mn |
| Dec 31, 2020 | 1.54 Mn |
| Sep 30, 2020 | 3.05 Mn |